ATP6V1E1
Basic information
Region (hg38): 22:17592136-17628749
Previous symbols: [ "ATP6E", "ATP6V1E" ]
Links
Phenotypes
GenCC
Source:
- autosomal recessive cutis laxa type 2C (Strong), mode of inheritance: AR
- autosomal recessive cutis laxa type 2, classic type (Supportive), mode of inheritance: AR
- autosomal recessive cutis laxa type 2C (Strong), mode of inheritance: AR
- autosomal recessive cutis laxa type 2C (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Cutis laxa, autosomal recessive, type IIC | AR | Cardiovascular | The condition can include early-onset cardiomyopathy, and awareness may allow early diagnosis and management | Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal | 28065471 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ATP6V1E1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 18 | 19 | ||||
missense | 30 | 33 | ||||
nonsense | 0 | |||||
start loss | 1 | |||||
frameshift | 0 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 4 | 7 | 2 | 13 | ||
non coding | 45 | 39 | 84 | |||
Total | 0 | 1 | 32 | 65 | 40 |
Variants in ATP6V1E1
This is a list of pathogenic ClinVar variants found in the ATP6V1E1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-17592497-T-C | Benign (Sep 11, 2018) | |||
22-17592651-G-A | Benign (Sep 11, 2018) | |||
22-17592681-A-G | Uncertain significance (Mar 12, 2022) | |||
22-17592686-C-T | Likely benign (Apr 25, 2024) | |||
22-17592687-T-A | not specified | Uncertain significance (Jan 19, 2025) | ||
22-17592691-T-A | Autosomal recessive cutis laxa type 2C | Uncertain significance (Feb 15, 2024) | ||
22-17592698-A-G | Likely benign (Sep 18, 2023) | |||
22-17592703-C-T | Uncertain significance (Mar 22, 2022) | |||
22-17592721-G-A | Autosomal recessive cutis laxa type 2C • RASopathy • Cutis laxa | Pathogenic/Likely pathogenic (Oct 21, 2024) | ||
22-17592739-G-A | Uncertain significance (Jun 13, 2021) | |||
22-17592745-A-G | Likely benign (Jan 24, 2023) | |||
22-17592751-T-C | Likely benign (Sep 28, 2022) | |||
22-17592766-A-G | Likely benign (May 10, 2019) | |||
22-17592800-CT-C | Benign (Aug 16, 2019) | |||
22-17592800-C-CT | Likely benign (Aug 08, 2019) | |||
22-17592800-C-CTT | Likely benign (Aug 06, 2019) | |||
22-17592800-C-CTTTT | Benign (Aug 10, 2019) | |||
22-17592888-C-T | Likely benign (Dec 29, 2018) | |||
22-17592920-T-C | Benign (Sep 22, 2018) | |||
22-17592945-G-A | Likely benign (Oct 12, 2019) | |||
22-17592981-G-A | Likely benign (Sep 29, 2018) | |||
22-17592998-C-T | Likely benign (Dec 29, 2018) | |||
22-17594513-G-A | Likely benign (Mar 09, 2024) | |||
22-17594514-T-C | Benign (Jan 29, 2025) | |||
22-17594539-A-G | Uncertain significance (Apr 16, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ATP6V1E1 | protein_coding | protein_coding | ENST00000253413 | 9 | 36683 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.528 | 0.471 | 125738 | 0 | 8 | 125746 | 0.0000318 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.59 | 68 | 116 | 0.585 | 0.00000581 | 1500 |
Missense in Polyphen | 5 | 19.43 | 0.25734 | 324 | ||
Synonymous | 0.160 | 36 | 37.2 | 0.967 | 0.00000171 | 387 |
Loss of Function | 2.88 | 3 | 15.1 | 0.199 | 7.26e-7 | 183 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000582 | 0.0000582 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000176 | 0.0000176 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000656 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Subunit of the peripheral V1 complex of vacuolar ATPase essential for assembly or catalytic function. V-ATPase is responsible for acidifying a variety of intracellular compartments in eukaryotic cells.;
- Pathway
- mTOR signaling pathway - Homo sapiens (human);Synaptic vesicle cycle - Homo sapiens (human);Phagosome - Homo sapiens (human);Epithelial cell signaling in Helicobacter pylori infection - Homo sapiens (human);Oxidative phosphorylation - Homo sapiens (human);Collecting duct acid secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);Rheumatoid arthritis - Homo sapiens (human);Signal Transduction;Transferrin endocytosis and recycling;Ion channel transport;adenosine ribonucleotides <i>de novo</i> biosynthesis;Insulin receptor recycling;Signaling by Insulin receptor;ROS, RNS production in phagocytes;Purine metabolism;Innate Immune System;Immune System;Transport of small molecules;superpathway of purine nucleotide salvage;Iron uptake and transport;Signaling by Receptor Tyrosine Kinases;purine nucleotides <i>de novo</i> biosynthesis;RANKL
(Consensus)
Recessive Scores
- pRec
- 0.118
Intolerance Scores
- loftool
- 0.0553
- rvis_EVS
- 0.04
- rvis_percentile_EVS
- 56.25
Haploinsufficiency Scores
- pHI
- 0.179
- hipred
- Y
- hipred_score
- 0.550
- ghis
- 0.596
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.895
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Atp6v1e1
- Phenotype
Zebrafish Information Network
- Gene name
- atp6v1e1b
- Affected structure
- eye photoreceptor cell
- Phenotype tag
- abnormal
- Phenotype quality
- decreased size
Gene ontology
- Biological process
- insulin receptor signaling pathway;ATP hydrolysis coupled proton transport;regulation of macroautophagy;transferrin transport;ion transmembrane transport;proton transmembrane transport
- Cellular component
- lysosomal membrane;endosome;cytosol;microvillus;apical plasma membrane;proton-transporting two-sector ATPase complex;proton-transporting two-sector ATPase complex, catalytic domain;extracellular exosome
- Molecular function
- protein binding;proton-exporting ATPase activity, phosphorylative mechanism;proton-transporting ATPase activity, rotational mechanism;ATPase binding